Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The potential of possibilities are absolutely mind boggling..
Pull up your boot straps and hang on for the ride..lol
Prior to Easy Check Breath-Meter coming to market, you said, "there are very powerful competitors, in the diabetes market, that absolutely want PSID to fail."
When, exactly, is the Easy Check Breath Meter scheduled to come to market, anyway..
You, also said, "PSID has the patents, has the financing, has the products and shortly will have the contracts and subsequent sales."
What contracts and subsequent sales will they have shortly, that you mentioned, which you are referring to..
IF PSID is not "indebted" to Ironside, as you mentioned..
What about the $14 million dollars worth of PSID shares, that Ironridge is supposedly holding, as was stated in Post #3628
Or, if, for some reason, that information was mistaken..
How much is PSID actually indebted to Ironridge for..
Tommy80 Wednesday, January 23, 2013 3:23:42 PM
Re: None Post #3628 of 3628
looking at ironridges website they still have psid in their portfolio.
so they still hold shares. who knows how many.
they got about $14 million worth.
so that is a lot to sell off.
sounds like every time pps goes up it might be them bringing it back down.
what i don't understand is (Future tranches of the transactions will include conversion pricing based on the market price of the common stock at the time of the tranche, subject to a minimum conversion price of $0.50)
i copied it and pasted it from old news. can someone explain this???
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83729891
Was this announcement confirmed..
If PSID is indebted 14 Million-dollars to Ironridge, as you mentioned..
I wonder how many Millions of PSID Shares that amounts to, that Ironridge will be selling off..
Tommy80 Wednesday, January 23, 2013 3:23:42 PM
Re: None Post #3628 of 3628
looking it ironridges website they still have psid in their portfolio.
so they still hold shares. who knows how many. they got about $14mil worth so that is a lot to sell off.
sounds like every time pps goes up it might be them bringing it back down.
what i don't understand is (Future tranches of the transactions will include conversion pricing based on the market price of the common stock at the time of the tranche, subject to a minimum conversion price of $0.50)
i copied it and pasted it from old news. can someone explain this???
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83729891
You'd think somebody-should put-out the word, somewhere, soon..
You posted PSID current liabilities is $4,850,000.
So, according to your information, I'm glad to hear that PSID isn't responsible for paying off their Accumulated Deficit Of Approximately $95 million, which I was concerned about, that I thought would, maybe, bankrupt them and put them out of business..
Accumulated deficit of approximately $95 million, as of June 30, 2012, according to this website link, below..
http://biz.yahoo.com/e/120820/psid10-q.html
Robsct Tuesday, January 22, 2013 6:11:17 AM
Re: greaseyfingers post# 3573 Post #3574 of 3600
Accumulated deficit is not debt. See what it means. Any start up company will have a negative accumulated deficit until they start having revenue. For us and for the operation of the company it doesn't really matter. It's an accounting gimmick.
"What does accumulated deficit mean under stockholder equity on a balance sheet?
Best Answer
It means that since the inception of the company they have lost more money than they have made. i.e. The total of there net income and net loss for each year they have been in existence is a net loss.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83661141
greaseyfingers Tuesday, January 22, 2013 5:10:53 AM
Re: Robsct post# 3555 Post #3573 of 3600
Accumulated deficit of approximately $95 million, as of June 30, 2012, according to this website link, below..
http://biz.yahoo.com/e/120820/psid10-q.html
Financial Condition
As of June 30, 2012, PSID had a working capital deficiency of approximately $3.9 million and an accumulated deficit of approximately $95 million, compared to working capital deficiency of approximately $2.7 million and an accumulated deficit of approximately $86 million as of December 31, 2011.
We have incurred operating losses prior to and since the merger that created PositiveID. The current operating losses are the result of selling, general and administrative expenses and research and development expenses. We expect our operating losses to continue through at least the remainder of 2012.
On January 20, 2012, we received an indemnification claim notice from Stanley related to the matter. We do not agree with the position taken by the CRA, and filed a formal appeal related to the matter on March 8, 2012. In connection with the filing of the appeal, Stanley was required to remit an upfront payment of a portion of the tax reassessment totaling approximately $950,000. We also filed a formal appeal related to the withholding tax assessments, pursuant to which Stanley was required to remit and upfront payment of approximately $220,000. We have agreed to repay Stanley for the upfront payments, plus interest at the rate of five percent per annum, in 24 equal monthly payments beginning on July 1, 2012. To the extent that we and Stanley reach a successful resolution of the matter through the appeals process, the upfront payment (or a portion thereof) will be returned to Stanley or us as applicable. Based on our review of the correspondence and evaluation of the supporting detail, we do not believe that the ultimate resolution of this matter will have a material negative impact on our historical tax liabilities or results of operations.
On August 31, 2011 we received notification that our stock was being delisted from the Nasdaq Capital Market ("Nasdaq") and on September 1, 2011 our stock began trading on the OTC Bulletin Board. The delisting from Nasdaq could adversely affect the market liquidity of our common stock and harm the business and may hinder or delay our ability to consummate potential strategic transactions or investments. Such delisting could also adversely affect our ability to obtain financing for the continuation of our operations and could result in the loss of confidence by investors, suppliers and employees.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83660654
bull_investor Friday, August 24, 2012 5:28:14 PM
Re: atrickpay post# 1248 Post #1253 of 3600
"..PSID is a scam or something.
PSID has actual lines of business. M-Band, DragonFly, iGlucose, Easy Check, Glucochip."
Yes - The products that are listed
--> Have they made any revenue?
As far as I know, they made "ZERO" revenue
--> not even $1000 dollars, for long time now I am waiting to see that day!
Maybe I am wrong, show me. I want to be wrong.
Also, do you know :
1. They have $86 million debt in books -- racked up (SEC Filings)
2. Both Mr.Cargol & Mr.Silverman(while active) - took home around $60k/month including bonus. (SEC Filings)
3. The above products of company have made "Zero" revenue quarter over quarter for long time now. (SEC Filings)
now, ask your same question "is PSID a scam or something?"
I don't know.
Now put that "Fire Sale" by Mr.Silverman somewhere in this picture -- you wonder why?
But do you see something obvious? no?
Disclaimer:- anything expressed above are just my humble opinions only.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=78908186
When PSID is-expected to skyrocket soon from speculation..
I'm wondering why some people are still selling their PSID shares and keeping the price down, instead of holding onto their shares, so the PSID share price starts going up..
It doesn't seem to make any sense to sell any PSID shares, at a time, when the speculation for PSID share price is expected to rise astronomically toward the moon.. IMO
PSID share price isn't much more than it's 52 week low..
So, why would anyone be selling their PSID stock shares, that cheap, and lose their position, when there isn't any significant profit, to be gained..
When the alternative would be, that hanging onto their PSID shares, could yield a much higher profit for them, if the price goes up, soon, as everyone here seems to be speculating that it will.. IMO
stockspirit Saturday, January 19, 2013 3:19:07 PM
Re: None Post #3534 of 3595
NOT trying to be negative.
If anyone wants PSID to move up IT IS ME.
I am confused though.
If all this good news is out, coming out and already known, then this stock should be flying.
All the info would be deseminated to employees, friends Boeing and everyone involved.
That's what happens with penny stocks.
Don't understand why it can't get moving.
It is a positive that we seem to be holding around .02. JMO
Your post was excellent for explaining the difference..
With that being said, it sounds like in a quick summarization..
Being PSID has an accumulated deficit of approximately $95 Million, which is a total net loss for each year they have been in existence..
And therefore, this money is not considered a debt obligation to be paid back to anyone..
And, as you stated, "It means that since the inception of the company they have lost more money than they have made. i.e. The total of there net income and net loss for each year they have been in existence is a net loss."
greaseyfingers Tuesday, January 22, 2013 5:10:53 AM
Re: Robsct post# 3555 Post #3573 of 3585
Accumulated deficit of approximately $95 million, as of June 30, 2012, according to this website link, below..
http://biz.yahoo.com/e/120820/psid10-q.html
Financial Condition
As of June 30, 2012, PSID had a working capital deficiency of approximately $3.9 million and an accumulated deficit of approximately $95 million, compared to working capital deficiency of approximately $2.7 million and an accumulated deficit of approximately $86 million as of December 31, 2011.
We have incurred operating losses prior to and since the merger that created PositiveID. The current operating losses are the result of selling, general and administrative expenses and research and development expenses. We expect our operating losses to continue through at least the remainder of 2012.
On January 20, 2012, we received an indemnification claim notice from Stanley related to the matter. We do not agree with the position taken by the CRA, and filed a formal appeal related to the matter on March 8, 2012. In connection with the filing of the appeal, Stanley was required to remit an upfront payment of a portion of the tax reassessment totaling approximately $950,000. We also filed a formal appeal related to the withholding tax assessments, pursuant to which Stanley was required to remit and upfront payment of approximately $220,000. We have agreed to repay Stanley for the upfront payments, plus interest at the rate of five percent per annum, in 24 equal monthly payments beginning on July 1, 2012. To the extent that we and Stanley reach a successful resolution of the matter through the appeals process, the upfront payment (or a portion thereof) will be returned to Stanley or us as applicable. Based on our review of the correspondence and evaluation of the supporting detail, we do not believe that the ultimate resolution of this matter will have a material negative impact on our historical tax liabilities or results of operations.
On August 31, 2011 we received notification that our stock was being delisted from the Nasdaq Capital Market ("Nasdaq") and on September 1, 2011 our stock began trading on the OTC Bulletin Board. The delisting from Nasdaq could adversely affect the market liquidity of our common stock and harm the business and may hinder or delay our ability to consummate potential strategic transactions or investments. Such delisting could also adversely affect our ability to obtain financing for the continuation of our operations and could result in the loss of confidence by investors, suppliers and employees.
Accumulated deficit of approximately $95 million, as of June 30, 2012, according to this website link, below..
http://biz.yahoo.com/e/120820/psid10-q.html
Financial Condition
As of June 30, 2012, PSID had a working capital deficiency of approximately $3.9 million and an accumulated deficit of approximately $95 million, compared to working capital deficiency of approximately $2.7 million and an accumulated deficit of approximately $86 million as of December 31, 2011.
We have incurred operating losses prior to and since the merger that created PositiveID. The current operating losses are the result of selling, general and administrative expenses and research and development expenses. We expect our operating losses to continue through at least the remainder of 2012.
On January 20, 2012, we received an indemnification claim notice from Stanley related to the matter. We do not agree with the position taken by the CRA, and filed a formal appeal related to the matter on March 8, 2012. In connection with the filing of the appeal, Stanley was required to remit an upfront payment of a portion of the tax reassessment totaling approximately $950,000. We also filed a formal appeal related to the withholding tax assessments, pursuant to which Stanley was required to remit and upfront payment of approximately $220,000. We have agreed to repay Stanley for the upfront payments, plus interest at the rate of five percent per annum, in 24 equal monthly payments beginning on July 1, 2012. To the extent that we and Stanley reach a successful resolution of the matter through the appeals process, the upfront payment (or a portion thereof) will be returned to Stanley or us as applicable. Based on our review of the correspondence and evaluation of the supporting detail, we do not believe that the ultimate resolution of this matter will have a material negative impact on our historical tax liabilities or results of operations.
On August 31, 2011 we received notification that our stock was being delisted from the Nasdaq Capital Market ("Nasdaq") and on September 1, 2011 our stock began trading on the OTC Bulletin Board. The delisting from Nasdaq could adversely affect the market liquidity of our common stock and harm the business and may hinder or delay our ability to consummate potential strategic transactions or investments. Such delisting could also adversely affect our ability to obtain financing for the continuation of our operations and could result in the loss of confidence by investors, suppliers and employees.
Your-estimate of $28.00 on the low-end, with multiple-splits, would be a dream come true..
I hope your predictions comes true..
liv4ree Wednesday, February 29, 2012 5:49:25 AM
Re: makingbiigdough post# 457 Post #465 of 3565
I'm thinking 3.00 to 5.00 if they land this contract. The diabetes technology is going to bring this stock way beyond 3.00 to 5.00 per share. My estimate is more in the neighborhood of 28.00 on the low end with multiple splits. Maybe I'm a dreamer, but I don't think so... BY the way, I'm not an educated stock guy by any stretch, just a work horse looking to make some money :) I don't want a buyout, I want this stock to play out long term. PSID knows what they have. The bio end of it is just the beginning, and will be the catalyst to the stock rising above it's current penny stock status. The real deal is the igloucose technology, and the glucochip. My gut tells me that this is the next Walmart/Microsoft stock. With Obama care lingering technology that will make diabetes monitoring more cost effective is huge. MBD educate me here, Is anyone else thinking this way?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=72657872
If your low ball PSID estimate comes true..
It will make a lot of rich and happy PSID Investors..
How much is PSID currently in debt for..
Wasn't PSID in debt for 89 MILLION DOLLARS, before, which is quite some time ago..
I wonder how much PSID is in debt for, now, if it was 89 MILLION DOLLARS that they were in debt for, before..
If PSID is obligated to pay 10 or 12 percent interest on their debt balance, that could add up to be many millions of more dollars being owed on the principal, from interest accumulating each year on this debt balance owed..
I hope PSID starts making a lot of money, soon, on this deal with Boeing..
If PSID could start earning, at least, 15 to 20 million dollars, yearly, in net profit..
Maybe, PSID could start paying off their large debt, if their greedy management personnel can stop paying themselves outrageous salaries and bonuses..
Is PSID management lacking credability with Investors..
Some Investors have long memories..
Could recalling PSID short comings, be holding the price down..
It's, obviously, deceptive and fraudulent, when PSID has been making false claims and statements, before, telling investors that they had signed strategic teaming agreements and partnered with IDEAL LIFE and SIMPLEX HEALTH CARE for marketing and selling iglucose to millions of their diabetes customers for generating PSID revenue from sales, which hasn't been done, yet, to my knowledge..
Sparky635 Sunday, November 04, 2012 1:09:02 AM
Re: greaseyfingers post# 2187 Post #2188 of 3535
It does appear that senior managers are not capable of selling anything. How can I take this company seriously if no one answers the phone during business hours?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=81121668
Robsct Thursday, August 23, 2012 3:21:57 PM
Re: atrickpay post# 1243 Post #1244 of 3535
Well, Silverman sold off over 11 million shares over several months so far this year. That's in the filings and explains why the bottom fell out of the pps.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=78862319
atrickpay Monday, November 05, 2012 1:31:37 PM
Re: greaseyfingers post# 2189 Post #2195 of 3535
Allison Tomek stopped responding to my inquiries two months ago. I'm wondering why...and why has there not been any insider buying of stock in the open market if the company is so undervalued?
And thirdly, just wtf happened to the order of 15000 units of iGlucose that was announced 10.20.2010?? Like come on...http://investors.positiveidcorp.com/releasedetail.cfm?ReleaseID=520694
DELRAY BEACH, Fla., Oct 20, 2010 (GlobeNewswire via COMTEX News Network) --
PositiveID Corporation ("PositiveID" or the "Company")
(Nasdaq:PSID)
announced today that it has received an initial order of 15,000 iGlucose(TM)units from Liberator Medical Holdings, Inc.("Liberator").
Liberator offers over 5,000 products to Medicare-eligible patient populations with chronic conditions requiring repeat-orders of maintenance supplies.
Scott R. Silverman, Chairman and CEO of PositiveID, said, "We are very pleased to announce this important distribution partner for our iGlucose product, Liberator Medical led by founder and CEO Mark Libratore.
As experts in the use of a national direct-to-consumer advertising model that has fueled the growth of Liberator Medical, we believe Mr. Libratore and his team can help us rapidly grow the awareness and adoption of iGlucose."
http://investors.positiveidcorp.com/releasedetail.cfm?ReleaseID=520694
stockspirit Saturday, January 19, 2013 3:19:07 PM
Re: None Post #3534 of 3535
NOT trying to be negative. If anyone wants PSID to move up IT IS ME. I am confused though. If all this good news is out, coming out and already known, then this stock should be flying. All the info would be deseminated to employees, friends Boeing and everyone involved. That's what happens with penny stocks. Don't understand why it can't get moving. It is a positive that we seem to be holding around .02. JMO
patiently waiting for PSID to skyrocket
Sooner or later
Hoping, it's sooner than later
PSID potential is looking even better
Quiver-Full Wednesday, January 16, 2013 11:09:59 PM
Re: None Post #3458 of 3458
I found this little nugget of information that I haven't seen on the board yet.
Caragol reported that PositiveID has "actually taken some inbound inquiries ... both from Europe, as well as from the Middle East, allies of the US inquiring about the ability to use the systems and implement the systems ... for the very same homeland protection that the US is looking to do." He claims that as the Bio Watch 3 program gains recognition as a successful project, international buyers will begin showing strong interest in implementing these same systems in their areas.
Here is the link to see this in the Small Cap Network Article
PositiveID Teams with Boeing for Big Profit Potential
good job calculating PSID anticipated valuation
Robsct Wednesday, January 16, 2013 7:15:37 PM
Re: greaseyfingers post# 3454 Post #3455 of 3455
The $6.00 pps valuation I figured for PSID was based on the companies projected revenue for the original deployment of 2500 units only. That does not include any foreign orders or the revenue from marketing other products. The revenue potential is huge and could easily justify a $12.00 share price.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83021549
greaseyfingers Wednesday, January 16, 2013 6:23:41 PM
Re: 411guy post# 3452 Post #3454 of 3456
You could become rich, if PSID reaches $10.00 to $12.00 dollars a share, like some people think it will..
liv4ree Monday, January 14, 2013 6:08:29 AM
Re: Quiver-Full post# 3389 Post #3390 of 3452
Your right Quiver. .15 is several dollars low on the PPS. But folks need to be patient. IMHO this is a 10.00 to 12.00 per share stock all day long.
411guy Wednesday, January 16, 2013 4:47:11 PM
Re: None Post #3452 of 3452
I am done buying PSID after today's purchase. Lets see where this goes. I am sitting on 250,000 shares. Hopefully this will be the breakout stock for 2013. Good luck.
You could become rich, if PSID reaches $10.00 to $12.00 dollars a share, like some people think it will..
liv4ree Monday, January 14, 2013 6:08:29 AM
Re: Quiver-Full post# 3389 Post #3390 of 3452
Your right Quiver. .15 is several dollars low on the PPS. But folks need to be patient. IMHO this is a 10.00 to 12.00 per share stock all day long.
411guy Wednesday, January 16, 2013 4:47:11 PM
Re: None Post #3452 of 3452
I am done buying PSID after today's purchase. Lets see where this goes. I am sitting on 250,000 shares. Hopefully this will be the breakout stock for 2013. Good luck.
Do you think that will happen this year
That's good to know..
When you think about the possibilities..
PSID has huge potential, if all it's products are properly developed and brought to market for earning revenue from sales..
illegalalien Monday, July 30, 2012 7:51:16 PM
Re: None Post #958 of 3432
What the future holds.
PSID owns near 30 U.S. and International patents on their technology. This isn't an opinion, it's a fact.
PSID has FDA approval on its diabetes technology which allows the company to sell its diabetes products to the public. Again, not an opinion, a fact.
PSID is one of two companies after the $5.7 billion dollar DHS BIoWatch contract. Someone earlier said the DHS contract provides that a "small company" to get 40% of the contract. I believe that statement is not true and here is why: PSID's BioWatch system is the ONLY system that performed "as advertised" in field test after field test with the DHS. Grummans on the other hand, did not. DHS is not going to award 60% of a $5.7 billion dollar contract to a company ( Grumman) whos product does not work. Personally, I believe, based on the previous, that PSID will partner with Boeing OR Grumman for the entire contract. I would not be surprised to see Grumman offer to buy the technology from PSID either. PSID is the only working system in this contract bidding. PSID will get the contract. This is a no brainer.
PSID's diabetes area is where I see the big money to lie. With a global market of $380 billion a year, PSID's IGlucose and EasyCheck devices are the new standard.
illegalalien Tuesday, August 07, 2012 8:57:17 PM
Re: Steelgoat post# 1066 Post #1071 of 3432
Don't lose sight of the fact the the current DHS contract will be the first of many. As more and more cities in this country implement the sniffers, and these units begin to be sold globally, $5.7 billion will be a drop in the bucket.
The DHS contract started out at about $3.7 billion, then jumped to $5.7. Don't be surprised if that number rises soon.
Scott-Silverman had around that many PSID shares, also, didn't he, before he started selling millions of them..
Does anyone know, right off hand, how many PSID shares Scott Silverman, currently, has left..
Scott Silverman and William Caragol, IMO, seem to be receiving way many PSID shares, without successfully generating much Company Revenue, so far, which is affecting Investor's share holder value..
Hopefully, PSID starts generating large revenues from selling and supplying reagents and assays to Boeing, if they're awarded a big portion of the DHS, BioWatch Gen3, M-Band, Contract..
If PSID can begin to successfully develop all of their products, and bring them to market, for generating revenue from sales, like it's Investors are waiting and expecting them to do..
PSID could turn out to be a very valuable investment for it's share holers, if things turn out, as they should..
Quiver-Full Thursday, January 10, 2013 11:01:36 PM
Re: None Post #3335 of 3371
There is a new 8-K for PositiveID as of 1/10/13
PositiveID Corp - SEC Filings
The biggest Change is that William Caragol now has 38,797,907 shares that he now owns. WOW... That's a lot of money when this stock shoots up to $6 :) ~ 232,000,000
That is a whole lot of compensation to the Directors / CEO.
post#3337
Lots of shares given in those 8k's. Not able to sell until January 1, 2016
from way I read it. The ceo has some that will become unrestricted January
15, 2015. So looks like they know where the price is going. Ceo even took
restricted shares for a 300k loan to company. He knows those shares will be
worth much more if they trading at multi dollars. Setting up to be a great
run here imo.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83299775
post#3339
They give away shares in PSID like it's toilet paper. Lots of shares for
sale down here. Going to take more good news to get it to move. JMO
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83312918
post#3340
I had a thought. Maybe they did this now because they think the pps will be
going up soon and then they would get less shares in exchange for what they
are owed?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83314645
post#3342
MBD, Im not getting any younger. When are we gonna get the next big news
thats going to send the PPS to the moon Alice?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83315455
Interesting Comment
Davecatchndawave Wednesday, January 09, 2013 7:43:48 PM
Re: greaseyfingers post# 3278 Post #3280 of 3360
The big fish swallowed the little fish. Happens every day. However, this little fish will not end up as poop, and WILL take it's place as a valued contributor with monthly earnings, and a very bright future!
IMO
PSID receiving 2.5 million from Boeing, seems-like peanuts, when this has the potential to be a 5.7 billion dollar contract..
Wasn't it around 36 million dollars that was spent, over 11 years, developing the BioWatch, M-Band, Generation3 technology that Boeing is, now, licensing from PSID for, only, 2.5 million dollars..
I'm surprised PSID isn't over 30 cents, yet..
Besides, as you mentioned, is PSID compensated anything-more..
At what price is each BioWatch, M-Band, Gen3 unit going to be sold for by Boeing..
Is it a certainty that there are going to be 2500 BioWatch Gen3 units purchased by the government's Department of Homeland Security..
How many of the 2500 units will the Department of Homeland Security be purchasing, seperately, from Northrop Grumman, and Boeing.. And over what time period does this occur..
How much profit will Boeing be making off each unit sold..
What percentage of Boeing's profit margin, of each unit sold, will PSID receive..
Or, doesn't PSID receive anything from Boeing's profit margin for each unit sold, being PSID has licensed BioWatch, M-Band, Gen3 to Boeing for 2.5 million dollars..
Hopefully, PSID will be more-successful than all-it's predecessors..
Otherwise, a lot of us are in the same boat..
I hope everyone knows how to swim, just in case we need to..lol
When PSID is-suppose to have such a promising-future for many investors hoping to get rich..
It seems counter intuitive that Silverman would be selling so many PSID, so cheap, when PSID is suppose to have such a promising future..
It, also, makes one wonder why Silverman wouldn't have waited til the price of PSID went up higher, before he started dumping millions of his PSID shares..
Or, do you think Silverman, possibly, knows a darkside about PSID that we aren't aware of..
I was reading from your provided website link, that I included part of, below, which stated..
Several steps remain before DHS can deploy and operate Gen-3. First, DHS must conduct additional performance and operational testing.
This testing--estimated to take 3 years and cost $89 million--is intended to demonstrate full system performance, including the information technology network.
To do so, the BioWatch program must address testing challenges including limitations on the use of live pathogens, among others.
Following operational testing, DHS intends to decide whether to authorize the production and deployment of Gen-3.
If Gen-3 is approved, the BioWatch program plans to prepare for deployment by working with BioWatch jurisdictions to develop location-specific plans to guide Gen-3 operations.
DHS estimates show that about $5.7 billion of the $5.8 billion life-cycle cost remains to be spent to test, produce, deploy, and operate Gen-3 through fiscal year 2028.
..................................................................
So, doesn't their wording basically say, more or less, what was said, in my own words. on post#2990
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
greaseyfingers Wednesday, January 02, 2013 8:09:17 AM
Re: None Post #2990 of 2990
To my understanding, Before HomeLand Security decides if they are going to go ahead and spend any more money than the allocated 89 million dollars..
To my understanding, The BioWatch Gen3 devices that are chosen by DHS to compete, first, need to pass their rigorous 2 to 3 years of stringent testing, by DHS, before any further government funding is possibly considered for continuing this program..
Which was suppose to be 3.1 to 5.7 billion dollars, if they would have gone ahead and fully implemented this program, now, washn't it?
So, besides the 2.5 million dollars that PSID is suppose to be getting paid from Boeing for the licensing agreement..
What else is PSID suppose to get out of the deal, any royalties, or percentages of devices sold, or does anybody know?
Robsct Wednesday, January 02, 2013 10:10:20 AM
Re: greaseyfingers post# 2990 Post #2994 of 2994
In a report by the Government Accounting Office (GAO) they recommended an additional testing phase and delayed deployment of the BioWatch system by DHS. The GAO also states that DHS has said they are not going to do this additional testing or delay the deployment of BioWatch. This was just a recommendation and not a law. Obama himself I believe has said publicly he is anxious to deploy BioWatch quickly. I include a link to info that squashes any unfounded rumors about this new testing phase being real. In the last paragraph the GAO says what the DHS response to their recommendation was!
" DHS concurred with the recommendations, but not the implementation timeline. DHS plans to proceed with the acquisition while implementing them to avoid further delays."
http://www.gao.gov/products/GAO-12-810
To my understanding, Before HomeLand Security decides if they are going to go ahead and spend any more money than the allocated 89 million dollars..
To my understanding, The BioWatch Gen3 devices that are chosen by DHS to compete, first, need to pass their rigorous 2 to 3 years of stringent testing, by DHS, before any further government funding is possibly considered for continuing this program..
Which was suppose to be 3.1 to 5.7 billion dollars, if they would have gone ahead and fully implemented this program, now, washn't it?
So, besides the 2.5 million dollars that PSID is suppose to be getting paid from Boeing for the licensing agreement..
What else is PSID suppose to get out of the deal, any royalties, or percentages of devices sold, or does anybody know?
Your Prediction of PSID going from 2-cents to 6-bucks, before 2013 is over..
Sounds like a Dream Come True..
I Hope Your Right..
Or, in the meantime, You Wouldn't Be Trying To Pull The Wool Over Some People's Eyes, Would You..
Davecatchndawave Monday, December 31, 2012 6:50:09 PM
Re: None Post # of 2976
Once a contract is awarded, I see 6 bucks before 2013 is over.
PieceofPie Monday, December 31, 2012 10:16:06 PM
Re: Davecatchndawave post# 2975 Post# 2977 of 2977
Why, may I ask, would you state such a high target at this point of the company growth? That makes it smack of such a scam stock like so many other pumpers plays out there.
I think, I would ask that you be a whole lot less of a
dreamer/pumper/pie-in-the-sky predictor and stay more real to the place we are in now.
No disrespect intended. Just do not want this board to look like a pump and dump site.
Happy New Year all.
PoP
The Heritage Foundation isn't a government "think tank"
The Heritage Foundation is an independent, tax-exempt institution. Heritage relies on the private financial support of the general public—individuals, foundations, and corporations—for its income, and accepts no government funds and performs no contract work. Heritage is one of the nation’s largest public policy research organizations. Its hundreds of thousands of individual members make it the most broadly supported think tank in America.
Website Link:
http://www.heritage.org/about
Robsct Sunday, December 30, 2012 11:06:37 AM
Re: None Post #2935 of 2963
This is a report done by the Heritage Foundation, a government "think tank". They make recommendations to the government about future policy decisions.
They recommend that the bio defense system should be refined AND continued and that's the path the government will follow. And PSID has the "next generation" of bio-sensors...
"While greater work is needed to refine both systems and ensure the timely and accurate detection of potentially hazardous pathogens, BioWatch is far from an “unnecessary expenditure.”"
http://www.heritage.org/research/reports/2012/07/biowatch-enhancing-biological-threat-detection
Prior to the award of the BioWatch Gen-3 performance testing contract, the program must be reviewed again by the ARB to determine if the program is able to meet the revised targets in the program plan.
Conclusion
DHS has worked diligently to improve its acquisition processes and these efforts have produced more effective governance and significant improvements to future and current acquisitions. The BioWatch program is an example of the successful application of the Department’s improved acquisition oversight process. The program has accepted feedback from the Department and been open to revising strategies to ensure that risk is balanced against benefits. I will continue to evaluate the risk of this program in my role as the Department’s Chief Acquisition Officer and will only provide authorization to proceed when pre-established criteria are met.
While there is still much work to do, the Department has made significant strides to improve acquisition and investment management for the Department’s portfolio of major programs. I believe we are making progress to shifting the paradigm so investment decisions are more empirically driven and there is qualified technical expertise to support program managers at each phase of the life cycle.
http://homeland.house.gov/sites/homeland.house.gov/files/Testimony%20Borras_1.pdf
Robsct Sunday, December 30, 2012 12:13:44 PM
Re: greaseyfingers post# 2949 Post #2950 of 2952
greasey...so what's your point? You're saying we should all run from PSID? Why are you here?
Bio Watch Gen-3 Investment and Acquisition Oversight Activities
Dr. Garza provides a detailed description of the history and objectives for the BioWatch program. I will, therefore, not repeat this information to the committee. It is clear that the program has a long history and its opportunity for success relies both on emerging technology and well-coordinated partnerships with industry, other federal agencies and state/local governments. The technical requirements for this technology are complex and I am pleased that our Science and Technology (S&T) Directorate is working closely with the Office of Health Affairs (OHA) on the technical strategy for the third generation (Gen-3). .
As indicated by Dr. Garza, there have been some schedule delays in the acquisition of Gen-3 technology for the BioWatch program because earlier generations were governed by outdated,
4
less rigorous standards. I am confident that our technical, acquisition and oversight environments are sufficiently settled so future generations of BioWatch equipment will be well supported.
S&T is in a unique position to evaluate new and emerging technologies against capability gaps, which will increase technological expertise and assist the Department in making better technology “buy” decisions. S&T and OHA are working closely to pursue this highly specialized detection technology while the Office of Program Accountability and Risk Management (PARM), which reports directly to me, is positioned to offer high quality acquisition management support.
In February 2012, the program requested I convene an ARB to obtain approval to release the BioWatch Gen-3 Phase II performance testing solicitation. Since the program had not completed the conditions set forth in prior program reviews, the BioWatch Gen-3 request was denied. Both the Program Management and Cost Estimating COEs worked with BioWatch Gen-3 on program and cost challenges to assist them in getting ready for this milestone. OHA submitted the required acquisition documentation for the program to the Department for review in July 2012.
The BioWatch program presents challenging acquisition issues under the most optimal circumstances, but this form of acquisition is not unique. There are no current, active procurements for BioWatch Gen-3. The first and second generations are in the operations and maintenance phase – and were prior to my tenure – while third generation technology is within the acquisition lifecycle and is currently working through technology demonstration and planning. As chair of the Acquisition Review Board, I will continue to monitor the progress of the program and will not allow Gen-3 to proceed unless it is meeting actions from the ADM.
http://homeland.house.gov/sites/homeland.house.gov/files/Testimony%20Borras_1.pdf
http://www.dtic.mil/ndia/2008homest/rhyne.pdf
PSID management owes investors explanations regarding all products..
First and Foremost, PSID management should be informing and explaining to all of it's investors, why both of their signed and strategic partnership teaming agreements, with both IDEAL LIFE and SIMPLEX HEALTH CARE never marketed and sold any Iglucose devices for increasing PSID Investors' share holder value, as PSID had announced and stated that both these two PSID partneringship companies, as mentioned, were going to do..
Many PSID investors bought millions of shares in the .08 cents price range, believing in PSID's announcement to be true and factual, concerning Iglucose..
The price of PSID, for the most part, has gone down ever since then, and has never recovered, again..
Even, if PSID is going to get paid 2.5 million from Boeing for licensing M-Band, BioWatch Gen3, to them..
How much good is 2.5 million going to do, in helping PSID, when they owe more than 86 million dollars to creditors..
I'm sure Boeing is more concerned about pursuing their own best interests, concerning the M-Band, BioWatch Gen3 system and profiting from it, than paying PSID anymore than they absolutely have to, in this regard..
PSID appears to be very vaque and negligent in keeping investors' updated, at all times, concerning it's products that are suppose to be going through development..
sayuncle Friday, December 28, 2012 9:59:06 PM
Re: None Post #2905 of 2905
PSID's last 10-K was rough... $86M in debt, bonuses for executive management. They have not even made a profit yet and are awarding themselves bonuses. Boeing better be real....still waiting.
PieceofPie Friday, December 28, 2012 11:08:26 PM
Re: greaseyfingers post# 2907 Post #2909 of 2909
Are you kidding me? If, in fact, management got this company to this point and negotiated a major deal with Boeing you damn well be giving them a bonus!!
Taking-a long-walk, off-a short-plank, is Pirate-Captain Black-Beards Bonus..
If PSID executive management had to earn a honest living, working for an employer, doing really hard pysical work, like a lot of people have to do for receiving a pay check..
I wonder how long they would last..
PSID executive management surely don't deserve receiving any kind of bonuses, when they haven't even made a profit, yet, for share holder investors..
sayuncle Friday, December 28, 2012 9:59:06 PM
Re: None Post # of 2905
PSID's last 10-K was rough... $86M in debt, bonuses for executive management. They have not even made a profit yet and are awarding themselves bonuses. Boeing better be real....still waiting.
Why-aren't you responding-accordingly, if you can comprehend reading-questions, regarding PSID, and What-forces are-causing the-price of PSID to remain so-low..
Pisd Friday, December 28, 2012 9:14:54 PM
Re: greaseyfingers post# 2898 Post #2899 of 2900
Hello,
Greaseyfingers and bull investor why would you be share holders if you are so against the company I don't get it. I think you should sell all your shares Monday morning, the rest of us already know all the negative things you are saying.
greaseyfingers Friday, December 28, 2012 9:03:32 PM
Re: None Post #2899 of 2900
What-forces are-causing the-price of PSID to remain so-low..
If Boeing is going to be such a big deal for PSID and it's investors..
Why aren't PSID share prices going substantially higher, in anticipation of the BioWatch Gen3, M-Band, being successful..
Is Silverman still busy dumping and selling his PSID shares, like before.
Or, is the PSID Corporation still creating more dilution, by selling more shares..
Does anything seem fishy to anyone else, when PSID stock price continues to remain so low, when PSID has already announced the licensing of M-Band, BioWatch Gen3 to Boeing, for 2.5 million dollars..
What-forces are-causing the-price of PSID to remain so-low..
If Boeing is going to be such a big deal for PSID and it's investors..
Why aren't PSID share prices going substantially higher, in anticipation of the BioWatch Gen3, M-Band, being successful..
Is Silverman still busy dumping and selling his PSID shares, like before.
Or, is the PSID Corporation still creating more dilution, by selling more shares..
Does anything seem fishy to anyone else, when PSID stock price continues to remain so low, when PSID has already announced the licensing of M-Band, BioWatch Gen3 to Boeing, for 2.5 million dollars..
Someone-wanted to know-how many PSID authorized shares there-are..
THE ANNUAL-MEETING OF STOCKHOLDERS WAS HELD-ON MAY-21, 2012
3. To approve and adopt an amendment to our certificate of incorporation to increase the total number of authorized shares of our capital stock from 180 million shares, of which 175 million shares are common stock, to 475 million shares, of which 470 million shares will be common stock;
Website Link to verify this information, as mentioned..
http://knobias.10kwizard.com/filing.php?param=&ipage=8192034&DSEQ=1&SEQ=3&SQDESC=SECTION_PAGE&exp=